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Purpose: The Wong-Kilbourne derivative of Chang conjunctiva-derived cell line has been widely used for toxicological
and functional in vitro studies on the ocular surface. The common reserve to this cell line is the reported contamination
with HeLa cells. Thus, the IOBA-NHC spontaneously immortalized conjunctival epithelial cell line has been recently
developed and did not show other cell type contamination. Our purpose was to determine whether both cell lines would
be equally suitable for in vitro toxicological studies. Therefore, we compared in these two cell types the toxic effects of
the preservative, benzalkonium chloride (BAC); its toxicity has been often reported on conjunctival in vivo and in vitro
models.
Methods: The necrotic, apoptotic, and oxidative effects of BAC were evaluated on Chang and IOBA-NHC cell lines
using microplate cytofluorometry tests (neutral red, 2,7- dichlorofluorescein diacetate dye [H2DCF-DA], hydroethidine,
and Yopro-1), flow cytometry (Annexin V/7-AAD and DNA content tests), and standard immunofluorescence stainings.
Cells were exposed to five concentrations of BAC (10−2%, 5.10−3%, 10−3%, 10−4%, and 10−5%) for two incubation times:
15 min of treatment and 15 min of treatment followed by 24 h of cell recovery in complete medium.
Results: All parameters of toxicity increased in a BAC dose-dependent manner on both cell lines.
Conclusions: The comparison of BAC toxicity on both cell lines supported the use of IOBA-NHC and Chang cells for
toxicological in vitro studies. Drawbacks of both cell lines have to be known and considered in studies performed on these
cell lines.
One of the best ways to investigate the ocular surface,
especially the conjunctival epithelium, is theoretically to get
human conjunctival biopsies that provide epithelial, stromal,
inflammatory, and goblet cells ex vivo [1]. However, these
samples are traumatic and cannot be used for research
purposes in benign conditions. Less invasive techniques like
conjunctival impression cytology or brush cytology have been
developed that allows immunological, physiopathological,
and toxicological studies but collect a limited number of cells
[2-5]. Therefore, cell cultures have been widely used for
investigating some pathophysiological aspects of the human
conjunctiva. Particularly, cell lines permit easy and quick cell
development and have the advantage over primary culture of
being independent from conjunctival biopsy availability.
Currently, the Wong-Kilbourne derivative of Chang
conjunctival cell line has been widely used for toxicological
and functional in vitro studies on ocular surface diseases. This
cell line has been immortalized from normal human
conjunctival epithelial cells but presents some characteristics
distinguishing it from normal tissue and primary cultures,
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particularly in their response to inflammatory cytokines like
tumor necrosis factor (TNFα) and interferon (IFNγ) [6].
Indeed, like other cell lines, it has acquired some differences
with normal conjunctiva in its phenotypic characteristics. But
the most common reserve to this cell line is the reported
contamination with HeLa cells [7]. Recently, Diebold et al.
[8] characterized the IOBA-NHC spontaneously
immortalized cell line that showed no other cell type
contamination but had some phenotypic differences with the
normal conjunctival epithelium. Our purpose was to evaluate
the relevance of the IOBA-NHC cell line in toxicological
research studies, determining whether these cell lines would
be fully comparable and suitable for toxicological in vitro
studies. As benzalkonium chloride (BAC) is a preservative
widely used in ophthalmic medications and is known to induce
toxic effects on conjunctival cells in vitro and in vivo [9-12],
its necrotic, apoptotic, and oxidative effects were evaluated
and compared in the present study on both cell lines.
METHODS
Conjunctival cell lines: IOBA-NHC cells were cultured under
standard conditions (humidified atmosphere of 5% CO2 at
37 °C) in DMEM/F12 supplemented with 1 µg/ml bovine
pancreas insulin, 2 ng/ml mouse epidermal growth factor, 0.1
Molecular Vision 2008; 14:394-402 <http://www.molvis.org/molvis/v14/a48>
Received 12 December 2007 | Accepted 14 February 2008 | Published 4 March 2008
© 2008 Molecular Vision
394µg/ml cholera toxin, 5 µg/ml hydrocortisone, 10% fetal
bovine serum (FBS), 50 UI/ml penicillin, and 50 UI/ml
streptomycin, as previously described [8].
The Wong-Kilbourne derivative of Chang conjunctival
cells (clone 1 to 5c-4l American Type Culture Collection
[ATCC, Manassas, VA]-certified cell line [CCL], 20.2) were
cultured under standard conditions (humidified atmosphere of
5% CO2 at 37 °C) in Dulbecco’s minimum essential medium
supplemented with 10% fetal bovine serum, 1% glutamine,
50 UI/ml penicillin, and 50 UI/ml streptomycin.
Cells from passages 5–50 were used in all experiments.
Every day, normal culture development was controlled by
phase-contrast microscopy. Cells were removed by gentle
trypsin incubation at confluence then counted. Then, they
were seeded into 96 well culture plates (Corning, Schiphol-
Rijk, the Netherlands) for microtitration analysis (5,000 cells
per well), in 12 well culture plates (TPP, Trasadingen,
Switzerland) for flow cytometric analysis (25,000 cells per
well), and on slides (Lab-tek II chambered coverglass; Nunc
International, Napierville, IL) for standard
immunofluorescence experiments. Cultures were kept at
37 °C for 24 h. Subconfluent cells (culture surface covering
nearly 70%) were then exposed to the different BAC
concentrations.
Cell treatments: Benzalkonium chloride was dissolved in
phosphate buffered saline (PBS). Five different
concentrations of BAC (10−2%, 5.10−3%, 10−3%, 10−4%, and
10−5%) were analyzed. Indeed, these concentrations are
equivalent to or lower than the concentrations of most
available eye-drops. Concentrations of 10−1% and higher were
not tested as they are known to be excessively toxic on
conjunctival cells in vitro, inducing cell lysis immediately
after treatment [10]. According to previously validated studies
under the same protocol [11], two incubation times were
applied to the cells: 15 min of treatment and 15 min of
treatment followed by 24 h of cell recovery in complete
medium. The 24-h cell recovery period was tested to approach
the clinical conditions in which the conjunctival tissue may
recover after eye drop instillation.
Microplate cytofluorometry: Microplate cytofluorometry was
performed on the Saphire Microplate reader (Tecan
Instruments, Lyon, France). Four different assays were used
according to previously validated methods [11,13-21]. As
previously described, neutral red stain (Fluka, Ronkonkoma,
NY) was used to evaluate membrane integrity, closely
correlated with cellular viability [15]. Reactive oxygen
species (ROS), particularly H2O2, were detected using the 2,7-
dichlorofluorescein diacetate dye (H2DCF-DA; Molecular
Probes, Eugene, OR) [16], and the hydroethidine probe was
used to detect the superoxide anion (O2
.-) production
(Molecular Probes, Eugene, OR) [17]. The Yopro-1 probe
(Molecular Probes, Eugene, OR) was used to evaluate
apoptosis as previously described, showing the opening of
specific membrane pores through the P2X7 cell death receptor
activation [18-21]. In all experiments, sterile phosphate
buffered saline (PBS) was used as the control. Microplate
cytofluorometry results were obtained in fluorescence units
and were expressed as a percentage of the control. Each drug
was tested in six wells (50 µl per well), and each experiment
was performed in triplicate. Hydroethidine, H2DCF-DA, and
Yopro-1 results were expressed using a ratio of the results of
these tests to those of the neutral red test to correlate them to
cellular viability.
Flow cytometry: Annexin/V-7AAD staining and DNA
content analysis are two apoptotic tests that were assessed by
flow cytometry on a FC 500-CXP flow cytometer (Beckman
Coulter, Miami, FL) equipped with an argon laser emitting at
488 nm [22,23]. Annexin V binds specifically to
phosphatidylserines that shift to the outer leaflet of the plasma
membrane during the early apoptotic process. 7-amino-
actinomycin D (7-AAD) is a fluorescent probe that
intercalates into nucleic acids of late apoptotic or necrotic
cells. After 24 h of culture in 12 well plates at 37 °C, cells
were incubated with the different BAC concentrations for 15
min. Then, they were incubated with ethylenediamine
tetraacetic acid (EDTA) at 1 mM, collected, and suspended in
1 ml PBS. Annexin V and 7-AAD were used as recommended
by the manufacturer (Beckman Coulter, Immunotech,
Luminy, France). A biparametric histogram was performed to
discriminate annexin V and 7-AAD, which would determine
four cell populations: cells negative to both markers (normal
viable cells), cells positive only to annexin V (early apoptotic),
cells positive to both annexin V and 7-AAD (late apoptotic),
and cells positive only to 7-AAD (necrotic).
Alteration of DNA content was measured through the
sub-G1 peak flow cytometric analysis on a FL4-fluorescence
histogram in a linear mode to characterize the late apoptosis
process. After 15 min of BAC treatment followed by 24 h of
cell recovery in complete medium, cells were collected using
EDTA as previously described and fixed with 0.5%
paraformaldehyde (PFA) fixative in PBS at 4 °C for 24 h.
After the 24 h fixation, samples were washed with cold PBS,
permeabilized in 0.1% saponin, stained with 50 µg/ml
propidium iodide (Interchim, Montluçon, France), and
analyzed on the flow cytometer. The sub-G1 region was
determined by a cursor defined in the controls and excluding
the debris as described previously [23].
Immunocytology: Standard immunofluorescence staining
under a confocal epifluorescence microscope (E800, PCM
2000; Nikon, Tokyo, Japan) was performed to assess
morphologic patterns of cells. Cells were cultured on chamber
slides (Lab-tek; Nalge Nunc International, Rochester, NY)
and incubated with the different BAC concentrations for 15
min. They were then washed with PBS and fixed for 15 min
with 4% PFA in PBS at 20 °C. Fluorescent phalloidin (200 U/
ml; Alexa 488, Molecular Probes) was then added to detect F-
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washed in PBS before propidium iodide staining and
microscopy examination.
Statistical analysis: Statistical comparisons were performed
with Sigma Stat 2.0 (SPSS, Chicago, IL). For the microplate
cytofluorometry data, significance was assessed using one-
way analysis of variance (ANOVA) followed by the Dunnett
test. The flow cytometry data were analyzed using one-way
ANOVA followed by the Bonferroni t-test.
RESULTS
Cell viability (neutral red probe): After a 15 min incubation
time, the membrane integrity decreased in a concentration-
dependent manner on the two cell lines (Figure 1). Thus, on
the Chang cell line, the most important toxicity was obtained
with BAC 10−2% (38% of the control, p<0.001 versus control)
followed by BAC 5.10−3% (56%, p<0.001) then BAC
10−3%, 10−4%, and 10−5% (95%, 98%, and 104%, respectively,
p=NS [not significant]). On IOBA-NHC cells, membrane
integrity results were 36% of the control with BAC 10−2%
(p<0.001), 56% with BAC 5.10−3% (p<0.001), 95% with BAC
10−3% (NS), 109% with BAC 10−4% (p<0.001), and 106%
with BAC 10−5% (p<0.05).
After 24 h of cell recovery (Figure 1), cellular viability
increased on both cell lines with BAC at 10−4% and 10−5%.
With BAC 10−3%, cellular viability increased on IOBA-NHC
cells and decreased on Chang cells while with BAC 5.10−3%
and 10−2%, cellular viability decreased on both cell lines.
Figure 1. Membrane integrity evaluation using the neutral red test on
Chang (WKD) and IOBA-NHC cells. This figure shows the
membrane integrity evaluation using the neutral red test (microplate
cytofluorometry) on Chang (WKD) and IOBA-NHC cells after two
incubation times, 15 min of treatment with different BAC
concentrations (WKD 15 min, IOBA-NHC 15 min) and 15 min of
treatment with different BAC concentrations followed by 24 h of cell
recovery in complete medium (WKD 24 h, IOBA-NHC 24 h). Note
that membrane integrity decreased in a concentration-dependent
manner on both cell lines. The asterisk denotes statistically
significant differences between the two cell lines after 15 min of
treatment (p<0.01), and the sharps (hash marks) denote statistically
significant differences between the two cell lines after 24 h of cell
recovery (### p<0.001, ## p<0.01, # p<0.05). BAC, benzalkonium
chloride; PBS, phosphate buffered saline. Means±SEM.
Reactive oxygen species detection (H2DCF-DA probe): After
a 15-min exposure time, the highest ROS production was
obtained with the highest BAC concentrations and varied in a
concentration-dependent manner (Figure 2). Indeed, on
Chang cells, the highest ratio was obtained with BAC 10−2%,
(3.52, p<0.001 versus control) followed by BAC 5.10−3%
(2.17, p<0.001) then BAC 10−3%, 10−4%, and 10−5% (1.05
[p=NS], 0.91 [p=NS], and 0.8 [p<0.001], respectively). On
IOBA-NHC cells, the highest ratio was also obtained with
BAC 10−2% (3.11, p<0.001) followed by BAC 5.10−3% (1.62,
p<0.001), BAC 10−3% (0.91, p=NS), 10−4% (0.76, p<0.01),
and 10−5% (0.84, p=NS).
After 24 h of cell recovery (Figure 2) in both cell lines,
small changes of ROS production were observed with BAC
concentrations of 10−3% and lower whereas ROS production
increased with BAC 5.10−3% and BAC 10−2%.
Superoxide anion detection (hydroethidine probe): After a 15
min exposure time, the highest superoxide anion production
was obtained with the highest BAC concentrations and
similarly increased in a concentration dependent manner
(Figure 3). On Chang cells, the highest ratio was obtained with
BAC 10−2% (3.57, p<0.001 versus control) followed by BAC
5.10−3% (2.28, p<0.001), but results were not different from
the control at the three other concentrations (ratios of 1.07,
1.01, and 1.04 for BAC 10−3%, 10−4%, and 10−5% [p=NS],
respectively). On IOBA-NHC cells, increased ratios were
obtained with BAC 10−2% (3.82, p<0.001) and BAC 5.10−3%
Figure 2. Reactive oxygen species detection using the H2DCF-DA
test on Chang (WKD) and IOBA-NHC cells. This figure shows the
reactive oxygen species (ROS) detection using the H2DCF-DA test
(microplate cytofluorometry) on Chang (WKD) and IOBA-NHC
cells after two incubation times, 15 min of treatment with different
BAC concentrations (WKD 15 min, IOBA-NHC 15 min) and 15 min
of treatment with different BAC concentrations followed by 24 h of
cell recovery in complete medium (WKD 24 h, IOBA-NHC 24 h).
Note that the highest ROS production was obtained with the highest
BAC concentrations and varied in a concentration-dependent manner
on both cell lines. The asterisk symbol denotes statistically
significant differences between the two cell lines after 15 min of
treatment (*p<0.01), and the sharps (hash mark) denote statistically
significant differences between the two cell lines after 24 h of cell
recovery (##p<0.001, #p<0.01). BAC, benzalkonium chloride; PBS,
phosphate buffered saline. Means ± SEM.
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396(1.59, p<0.01). BAC 10−3% was not different from the control
(0.93, p=NS), and BAC 10−4% and 10−5% significantly
decreased superoxide anion production (ratios of 0.92 and
0.74 [p<0.05], respectively).
After 24 h of cell recovery (Figure 3), superoxide anion
production increased with the five BAC concentrations on
Chang cells. On IOBA-NHC cells, superoxide anion
production was increased with BAC 5.10−3%, and decreased
with the other four BAC concentrations.
Yopro-1 test—After 15 min of cell exposure to the
different concentrations of BAC, we observed that the
Yopro-1/neutral red ratio consistently increased with BAC
concentration (Figure 4).
On Chang cells, ratios were 9.04, 8, 2.17, 2.18, and 2.19
(p<0.001 versus control for all values) for BAC 10−2%, 5.
10−3%, 10−3%, 10−4%, and 10−5%, respectively. On IOBA-
NHC cells, lower ratios were obtained, 7.29 (p<0.001), 4.05
(p<0.001), 1.64 (p<0.001), 1.32 (p<0.05), and 1.29 (p=NS)
for BAC 10−2%, 5.10−3%, 10−3%, 10−4%, and 10−5%,
respectively.
After 24 h of cell recovery (Figure 4), the ratios decreased
with the five BAC concentrations on Chang cells whereas only
minor changes were observed on IOBA-NHC cells.
Annexin/V-7AAD staining—For the total toxic effect
evaluation (apoptotic and necrotic cells), results were
expressed in percentage of cells engaged in a cell death
process. With this global parameter, the same toxicity profiles
were obtained on the two cell lines with BAC concentration-
Figure 3. Superoxide anion detection using the hydroethidine test on
Chang (WKD) and IOBA-NHC cells. This figure shows the
superoxide anion detection using the hydroethidine test (microplate
cytofluorometry) on Chang (WKD) and IOBA-NHC cells after two
incubation times, 15 min of treatment with different BAC
concentrations (WKD 15 min, IOBA-NHC 15 min) and 15 min of
treatment with different BAC concentrations followed by 24 h of cell
recovery in complete medium (WKD 24 h, IOBA-NHC 24 h). Note
that the highest superoxide anion production was obtained with the
highest BAC concentrations and varied in a concentration-dependent
manner on both cell lines. The asterisk symbol denotes statistically
significant differences between the two cell lines after 15 min of
treatment (*p<0.05), and the sharp (hash mark) denotes statistically
significant differences between the two cell lines after 24 h of cell
recovery (#p<0.001). BAC, benzalkonium chloride; PBS, phosphate
buffered saline. Means ± SEM.
dependent cell toxicity (Figure 5). On Chang cells, the
percentage of apoptotic or necrotic cells were 88.2% (p<0.001
versus control), 84.7% (p<0.001), 29.9% (p<0.01), 31.4%
(p<0.01), and 27.3% (p<0.05) for BAC 10−2%, 5.10−3%,
10−3%, 10−4%, and 10−5%, respectively. Similar results were
obtained on IOBA-NHC cells, with percentages of 92.9%
(p<0.001), 74.1% (p<0.001), 27.5% (p<0.001), 17.1%
(p=NS), and 17.4% (p=NS) for BAC 10−2%, 5.10−3%,
10−3%, 10−4%, and 10−5%, respectively.
With the Annexin/V-7 AAD test, we also analyzed the
early apoptotic, late apoptotic, and necrotic cell populations
(Figure 6), discriminated as described previously.
Particularly, we showed that on Chang cells, the late apoptotic
cell population was significantly increased with BAC at
10−5% (10.4%, p<0.01 versus control) and with BAC at
10−4% (14.6%, p<0.001). Conversely, when concerning the
early apoptotic and necrotic cell populations in Chang cells or
the early apoptotic, late apoptotic, and necrotic cell
populations in IOBA cells, no statistically significant
difference was shown between these same BAC
concentrations and PBS. With BAC 10−3%, the late apoptotic
cell population was significantly increased in both Chang cells
(10.3%, p=0.02 versus control) and IOBA-NHC cells (14.5%,
p=0.042) whereas the early apoptotic and the necrotic cell
populations were not significantly increased in both cell lines.
In addition, no statistically significant difference was found
between the two cell lines in the late apoptotic cell population
with BAC 10−3%. With BAC 5.10−3%, on Chang cells, the
Figure 4. Apoptosis assay using the Yopro-1 test on Chang (WKD)
and IOBA-NHC cells. This figure shows the results of the Yopro-1
apoptosis assay (microplate cytofluorometry) on Chang (WKD) and
IOBA-NHC cells after two incubation times, 15 min of treatment
with different BAC concentrations (WKD 15 min, IOBA-NHC 15
min) and 15 min of treatment with different BAC concentrations
followed by 24 h of cell recovery in complete medium (WKD 24 h,
IOBA-NHC 24 h). Note that the Yopro-1/neutral red ratio that is
correlated to cell apoptosis consistently increased with BAC
concentration on both cell lines. The asterisk symbols denote
statistically significant differences between the two cell lines after
15 min of treatment (**p<0.001, *p<0.01), and the sharps (hash
mark) denote statistically significant differences between the two cell
lines after 24 h of cell recovery(##p<0.001, #p<0.05). BAC
benzalkonium chloride; PBS, phosphate buffered saline. Means ±
SEM.
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397percentages of late apoptotic cells and necrotic cells in Chang
cells were 21.9% and 59.7% (p<0.05 versus control),
respectively. On IOBA-NHC cells, there was a higher
percentage of late apoptotic cells (53.1%, p<0.001 versus
control) and a lower percentage of necrotic cells (15.4%,
p<0.05 versus control) with BAC at 5.10−3%.
DNA content—Results were expressed in the percentage
of sub-G1 events when compared to the total cell population
after 15 min of treatment followed by 24 h cell recovery in
normal culture medium (Figure 7). The same toxicity profiles
were similarly obtained on both cell lines with this test.
Indeed, percentages on Chang cells were 96.6% (p<0.001
compared with control), 86.8% (p<0.001), 28.8% (p<0.01),
17.9% (p=NS), and 16% (p=NS) for BAC 10−2%, 5.10−3%,
10−3%, 10−4%, and 10−5%, respectively, and on IOBA-NHC
cells, the percentages were 91.3% (p<0.001%), 69.9%
(p<0.001), 28.1% (p<0.05), 17.6% (p=NS), and 16.6%
(p=NS), respectively, for the same BAC concentrations.
Immunocytology: Cell shrinkage increased in a BAC
concentration-dependent manner after phalloidin and
propidium iodide staining. Thus, we observed a high cell
shrinkage with BAC 10−2% (Figure 8) and BAC 5.10−3% as
well as intermediate changes with BAC 10−3% on both cell
lines. No effect was shown with BAC 10−4% and 10−5%.
DISCUSSION
Cell cultures are generally considered to be a good alternative
to animal studies for investigating the pathophysiology of
human diseases. Particularly, cell lines permit easy, quick,
cheap cell growth, small variations of experimental
conditions, and better reproducibility than primary cultures.
Figure 5. Total toxic effect evaluation using the Annexin/V-7AAD
staining on Chang (WKD) and IOBA-NHC cells. This figure shows
the total toxic effect (apoptotic and necrotic cells) using the Annexin/
V-7AAD test (flow cytometry) after 15 min of treatment with
different concentrations of BAC on Chang (WKD) and IOBA-NHC
cells. Note that the same toxicity profiles were obtained on both cell
lines with BAC concentration-dependent cell toxicity. The asterisk
symbols denote statistically significant differences between the two
cell lines (**p<0.001, *p<0.05). BAC, benzalkonium chloride; PBS,
phosphate buffered saline. Means ± SEM.
Currently, several continuous epithelial cell lines from the
human conjunctiva have been developed. A few transformed
cell lines have been reported and used for toxicological and
functional studies [24-26], but only two untransfected cell
lines have been developed, the Wong-Kilbourne derivative of
Chang conjunctival cell line (clone 1 to 5c-4l American Type
Culture Collection [ATCC, Manassas, VA]-certified cell line
[CCL], 20.2) and the IOBA-NHC cell line. The Wong-
Kilbourne derivative of Chang conjunctival cell line, the first
continuous, untransfected epithelial cell line from normal
human conjunctiva established, has been widely used in
previous studies, particularly for the assessment of the toxicity
of preservatives like benzalkonium chloride and preserved
anti-glaucoma or anti-allergic eye drops [10-13,27,28].
Several functional studies have also been performed on this
cell line [29,30], and its morphological and functional
characteristics have been compared with primary culture of
Figure 6. Discrimination of the early apoptotic, late apoptotic, and
necrotic cell populations using the Annexin/V-7 AAD test on Chang
(WKD) and IOBA-NHC cells. Annexin/V-7 AAD staining results
(flow cytometry) show the early apoptotic, late apoptotic, and
necrotic cell populations after 15 min of treatment with different
concentrations of BAC on (A) Chang (WKD) and (B) IOBA-NHC
cells. Note that BAC toxicity (late apoptosis) was found with BAC
at 10−5% and 10−4% in Chang cells whereas on IOBA-NHC cells, the
toxicity was only found with BAC at 10−3% and higher, and that with
BAC at 5.10−3%, most of IOBA-NHC cells were in a late apoptotic
process whereas most of Chang cells were necrotic. Statistical results
are not shown (developed in the results section). BAC, benzalkonium
chloride; PBS, phosphate buffered saline. Means ± SEM.
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398human conjunctival epithelium, underlining the
immunomodulatory functions of both cell culture models in
the localized inflammatory response [6,31]. However, the
Wong-Kilbourne derivative of Chang conjunctival cells have
HeLa marker chromosomes and the variant A of the enzyme,
glucose-6-phosphate dehydrogenase, that could interfere with
the interpretation of the results [7,32]. In 2003, Diebold et al.
developed and characterized a spontaneously immortalized
cell line from normal human conjunctiva called the IOBA-
NHC cell line, which showed no other cell type contamination
[8]. Like Chang cells, IOBA-NHC cells showed some
morphological and functional characteristics of normal
conjunctival epithelial cells like cytokeratin expression,
presence of specialized adherent junctions between cells, and
microvilli on the cell surface. However, like other cell lines,
IOBA-NHC cells also showed some phenotypic and
karyotypic differences with normal conjunctival epithelium.
Nevertheless, this cell line has been used in functional and
toxicological studies [33-38], but to our knowledge, no
comparison of toxicological profiles of both Chang and
IOBA-NHC cell lines have been performed. Thus, our
purpose was to determine whether both cell lines are suitable
and fully comparable for toxicological studies in vitro.
Therefore, we compared both cell lines for the pro-necrotic,
pro-apoptotic, and pro-oxidative effects of BAC, mainly used
in ophthalmic solutions and which toxic effects are well
known and have been widely reported on Chang cells [10,
11].
In this study, all parameters of toxicity measured
increased in a BAC dose-dependent manner on both cell lines.
Indeed, the highest toxicity was obtained with the highest
BAC concentrations on both Chang and IOBA-NHC cells
after a 15 min exposition time and after 24 h of cell recovery.
Figure 7. Alteration of DNA content analysis on Chang (WKD) and
IOBA-NHC cells The alteration of DNA content was measured
through the sub-G1 peak flow analysis (flow cytometry) on Chang
(WKD) and IOBA-NHC cells after 15 min of cell exposure with the
different concentrations of BAC followed by 24 h of cell recovery.
Note that the same toxicity profiles were obtained on both cell lines
with BAC concentration-dependent cell toxicity. The asterisk
symbols denote statistically significant differences between the two
cell lines (**p<0.001, *p<0.01). BAC, benzalkonium chloride; PBS,
phosphate buffered saline. Means ± SEM.
In addition, the BAC threshold concentration observed was
BAC at 5.10−3% on both cell lines. These results were
consistent with previous studies by De Saint Jean et al. [10]
and Debbasch et al. [11] on Chang cells, who also noted a
BAC dose-dependent increase in cell toxicity following
exposure to BAC at different concentrations. In the present
study, BAC toxicity was tested after two incubation times, 15
min of treatment and 15 min of treatment followed by 24 h of
cell recovery in complete medium, to compare and understand
both cell line behaviors and to approach the in vivo
regeneration capacities of the conjunctival tissue. Thus, after
the 24 h cell recovery period, we observed that BAC toxicity
also increased in a concentration-dependent manner in the two
cell lines and that the BAC threshold concentration was
unchanged. With the neutral red and the H2DCF-DA tests,
higher cellular damages were observed after the 24 h recovery
period with BAC at 5.10−3% and above on both cell lines, their
regeneration capacities were probably beyond their limits
under these BAC concentrations. With the hydroethidine test
that was used to detect the superoxide anion (O2
-) production,
cell toxicity increased after the 24 h recovery period on Chang
cells but tended to decrease on IOBA-NHC cells except with
a BAC concentration at 5.10−3%. Conversely, using the
Yopro-1 test, we observed that the Yopro-1/neutral red ratio
consistently decreased on Chang cells unlike on IOBA-NHC
cells after 24 h of cell recovery. Thus, further experiments
could be useful to study the cell characteristics potentially
involved in these different cell behaviors such as the oxidative
or anti-oxidative status of each cell line or the P2X7 cell death
receptor expression after a single 15 min incubation time and
after the 24 h recovery period.
In the present study, other small differences have been
found between the two conjunctival cell lines. Indeed, BAC
toxicity seemed to be higher on the Chang cell line than on
the IOBA-NHC cell line, suggesting a higher sensitivity in
Chang cells toward the toxic effects of BAC. With the
sensitive Annexin/V-7AAD apoptosis test, a BAC toxicity
(late apoptosis) was found with BAC at 10−5% and 10−4% in
Chang cells whereas on IOBA-NHC cells, the toxicity was
only shown with BAC at 10−3% and higher. With BAC at
5.10−3%, most of IOBA-NHC cells were in a late apoptotic
process whereas most of Chang cells were necrotic,
underlining the higher sensitivity of Chang cells. Several
factors could explain thethese differences: the mitochondrial
cells status, the expression or activation of cell death receptors
(tumor necrosis factor, P2X7, or Fas receptors), or the factors
or enzymes implicated in the oxidative stress (catalases,
superoxide dismutases, glutathione peroxidases, glutathione)
or in the apoptotic process (caspases, DNases). Another
parameter that could explain these differences is the
supplementation of IOBA-NHC cell culture medium with
several components like mouse epidermal growth factor and
hydrocortisone that could enhance the resistance of cells
against BAC. In addition, with the neutral red test, cellular
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399viability was significantly increased in IOBA-NHC cells with
BAC at 10−5% and 10−4% after 15 min of cell treatment but
mostly after 24 h of cell recovery. This effect could be
explained by a higher cell growth of this cell line compared
to Chang cells, but further experiments are required to confirm
this hypothesis.
In the present study, the Wong-Kilbourne derivative of
Chang conjunctival cells seemed to have a high sensitivity to
BAC. These data suggest that the HeLa cell contamination to
Wong-Kilbourne derivative of Chang conjunctival cells does
not affect the usefulness of the cell line, supporting the use of
Chang cells for toxicological, in vitro studies. Thus, as it has
been previously reported, mild toxic effects of preservative or
other potentially toxic agents can be accurately screened using
this cell line [12,13,27,28,39] despite its contamination with
HeLa cells. In addition, in this study, we showed a dose-
dependent toxicity of BAC in IOBA-NHC cells, supporting
the use of this cell line for toxicological in vitro studies as
well, particularly for the comparison of apoptotic or oxidative
effects of different ophthalmic medications. However, the
interpretation of the studies performed on IOBA-NHC cells
must consider the potential lower sensitivity of these cells and
their culture medium composition. In every instance,
toxicological or immunological studies require
complementary tests and techniques to validate any in vitro
experimental result, particularly if the aim is to confirm the
innocuousness of an agent that could appear toxic on various
models or using other techniques. Moreover, as Chang and
IOBA-NHC cell lines are in vitro models, results obtained
with each cell line cannot fully be extrapolated to in vivo
conditions. In vivo, cells are protected with the action of the
eyelids, the preocular mucin layer, and glycocalyx, and there
is a permanent renewal of ocular surface epithelia. Tissues
have high regeneration and defense capacities, and the
conjunctival epithelium has a stratified structure that enhances
protection of the ocular surface against preservative toxicity.
Furthermore, our findings are insufficient to strictly validate
the use of IOBA-NHC or Chang cells for toxicological
studies. Validation of any new alternative method that has
been defined by the demonstration of the reliability and
relevance of a test method for a particular purpose must be
demonstrated in an independent, scientifically sound
validation program [40]. Currently, the only alternative
method that has been validated as predictive of the ocular
Figure 8. Standard immunofluorescence
staining on Chang (WKD) and IOBA-
NHC cells. Phalloidin and propidium
iodide stainings show the morphology
of Chang cells (A,B) and IOBA-NHC
cells (C,D) after 15 min of treatment
with solutions of PBS (A,C) and BAC
10−2% (B,D). Nuclei were stained in red
by propidium iodide and cytoskeleton
(F-actin) in green by phalloidin. Note
the BAC-dependent increase of cell
shrinkage on both cell lines. BAC,
benzalkonium chloride; PBS, phosphate
buffered saline.
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this model is subjective and flawed. However, several
alternative in vitro methods have been developed over the past
20 years to replace it [42].
In conclusion, this present study demonstrates that the
comparison of BAC toxicity on both Chang and IOBA-NHC
cell lines supported the use of IOBA-NHC cells for
toxicological studies in vitro and validated previous studies
performed on the Chang cells despite their reported
contamination with HeLa cells. Thus, our findings confirm
that both cell lines are useful for toxicological in vitro studies
as their respective disadvantages are known and discussed.
Particularly, IOBA-NHC cells, which showed no other cell
type contamination, are cultured in a medium that is
supplemented with epidermal growth factor (EGF),
hydrocortisone, and cholera toxin, factors which may be
potentially implicated in the cell resistance against a toxic
agent like BAC. Further studies could be performed to
determine whether the deprivation of each factor could
modify cell functional behavior and morphologic
characteristics. Other factors could influence cell sensitivity
to xenobiotics like the oxidative or mitochondrial status of
tested cells and the expression of death receptors that could
be characterized in further studies. Moreover, comparison of
the characteristics of both cell lines will deserve further
interest to complete the validation of the usefulness of these
cell lines for functional studies.
ACKNOWLEDGMENTS
We would like to thank Y. Diebold and C. Creuzot-Garcher
for supplying the IOBA-NHC cells. This study was supported
by unrestricted grants from INSERM (UMR S 872)
REFERENCES
1. Egbert PR, Lauber S, Maurice DM. A simple conjunctival
biopsy. Am J Ophthalmol 1977; 84:798-801. [PMID:
596392]
2. Baudouin C, Brignole F, Becquet F, Pisella PJ, Goguel A. Flow
cytometry in impression cytology specimens. A new method
for evaluation of conjunctival inflammation. Invest
Ophthalmol Vis Sci 1997; 38:1458-64. [PMID: 9191610]
3. Baudouin C, Garcher C, Haouat N, Bron A, Gastaud P.
Expression of inflammatory membrane markers by
conjunctival cells in chronically treated patients with
glaucoma. Ophthalmology 1994; 101:454-60. [PMID:
7907416]
4. Rolando M, Terragna F, Giordano G, Calabria G. Conjunctival
surface damage distribution in keratoconjunctivitis sicca. An
impression cytology study. Ophthalmologica 1990;
200:170-6. [PMID: 2367078]
5. Tseng SC. Staging of conjunctival squamous metaplasia by
impression cytology. Ophthalmology 1985; 92:728-33.
[PMID: 3897935]
6. De Saint Jean M, Baudouin C, Di Nolfo M, Roman S, Lozato
P, Warnet JM, Brignole F. Comparison of morphological and
functional characteristics of primary-cultured human
conjunctival epithelium and of Wong-Kilbourne derivative of
Chang conjunctival cell line. Exp Eye Res 2004; 78:257-74.
[PMID: 14729358]
7. Lavappa KS. Survey of ATCC stocks of human cell lines for
HeLa contamination. In Vitro 1978; 14:469-75. [PMID:
566722]
8. Diebold Y, Calonge M, Enriquez de Salamanca A, Callejo S,
Corrales RM, Saez V, Siemasko KF, Stern ME.
Characterization of a spontaneously immortalized cell line
(IOBA-NHC) from normal human conjunctiva. Invest
Ophthalmol Vis Sci 2003; 44:4263-74. [PMID: 14507870]
9. Becquet F, Goldschild M, Moldovan MS, Ettaiche M, Gastaud
P, Baudouin C. Histopathological effects of topical
ophthalmic preservatives on rat corneoconjunctival surface.
Curr Eye Res 1998; 17:419-25. [PMID: 9561834]
10. De Saint Jean M, Brignole F, Bringuier AF, Bauchet A,
Feldmann G, Baudouin C. Effects of benzalkonium chloride
on growth and survival of Chang conjunctival cells. Invest
Ophthalmol Vis Sci 1999; 40:619-30. [PMID: 10067965]
11. Debbasch C, Brignole F, Pisella PJ, Warnet JM, Rat P,
Baudouin C. Quaternary ammoniums and other preservatives'
contribution in oxidative stress and apoptosis on Chang
conjunctival cells. Invest Ophthalmol Vis Sci 2001;
42:642-52. [PMID: 11222522]
12. Debbasch C, Pisella PJ, De Saint Jean M, Rat P, Warnet JM,
Baudouin C. Mitochondrial activity and glutathione injury in
apoptosis induced by unpreserved and preserved beta-
blockers on Chang conjunctival cells. Invest Ophthalmol Vis
Sci 2001; 42:2525-33. [PMID: 11581193]
13. Guenoun JM, Baudouin C, Rat P, Pauly A, Warnet JM,
Brignole-Baudouin F. In vitro comparison of cytoprotective
and antioxidative effects of latanoprost, travoprost, and
bimatoprost on conjunctiva-derived epithelial cells. Invest
Ophthalmol Vis Sci 2005; 46:4594-9. [PMID: 16303954]
14. Plantin-Carrenard E, Bringuier A, Derappe C, Pichon J, Guillot
R, Bernard M, Foglietti MJ, Feldmann G, Aubery M, Braut-
Boucher F. A fluorescence microplate assay using yopro-1 to
measure apoptosis: application to HL60 cells subjected to
oxidative stress. Cell Biol Toxicol 2003; 19:121-33. [PMID:
12776929]
15. Borenfreund E, Puerner JA. Toxicity determined in vitro by
morphological alterations and neutral red absorption. Toxicol
Lett 1985; 24:119-24. [PMID: 3983963]
16. Rat P, Osseni R, Christen MO, Thevenin M, Warnet JM,
Adolphe M. Microtitration fluorimetric assays on living cells
(MiFALC tests): new tools for screening in cell
pharmacotoxicology. In: Van Zutphen LFM, Balls M, editors.
Animal alternatives, welfare and ethics. Amsterdam:
Elsevier; 1997. p.813–825.
17. Budd SL, Castilho RF, Nicholls DG. Mitochondrial membrane
potential and hydroethidine-monitored superoxide generation
in cultured cerebellar granule cells. FEBS Lett 1997;
415:21-4. [PMID: 9326361]
18. Idziorek T, Estaquier J, De Bels F, Ameisen JC. YOPRO-1
permits cytofluorometric analysis of programmed cell death
(apoptosis) without interfering with cell viability. J Immunol
Methods 1995; 185:249-58. [PMID: 7561136]
19. Dutot M, Pouzaud F, Larosche I, Brignole-Baudouin F, Warnet
JM, Rat P. Fluoroquinolone eye drop-induced cytotoxicity:
role of preservative in P2X7 cell death receptor activation and
Molecular Vision 2008; 14:394-402 <http://www.molvis.org/molvis/v14/a48> © 2008 Molecular Vision
401apoptosis. Invest Ophthalmol Vis Sci 2006; 47:2812-9.
[PMID: 16799018]
20. Suh BC, Kim JS, Namgung U, Ha H, Kim KT. P2X7 nucleotide
receptor mediation of membrane pore formation and
superoxide generation in human promyelocytes and
neutrophils. J Immunol 2001; 166:6754-63. [PMID:
11359833]
21. Gibbons SJ, Washburn KB, Talamo BR. P2X(7) receptors in
rat parotid acinar cells: formation of large pores. J Auton
Pharmacol 2001; 21:181-90. [PMID: 11952873]
22. Eckstein LA, Van Quill KR, Bui SK, Uusitalo MS, O'Brien JM.
Cyclosporin a inhibits calcineurin/nuclear factor of activated
T-cells signaling and induces apoptosis in retinoblastoma
cells. Invest Ophthalmol Vis Sci 2005; 46:782-90. [PMID:
15728531]
23. Nicoletti I, Migliorati G, Pagliacci MC, Grignani F, Riccardi C.
A rapid and simple method for measuring thymocyte
apoptosis by propidium iodide staining and flow cytometry.
J Immunol Methods 1991; 139:271-9. [PMID: 1710634]
24. Gipson IK, Spurr-Michaud S, Argüeso P, Tisdale A, Ng TF,
Russo CL. Mucin gene expression in immortalized human
corneal-limbal and conjunctival epithelial cell lines. Invest
Ophthalmol Vis Sci 2003; 44:2496-506. [PMID: 12766048]
25. Smit EE, Sra SK, Grabowski LR, Ward SL, Trocme SD.
Modulation of IL-8 and RANTES release in human
conjunctival epithelial cells: primary cells and cell line
compared and contrasted. Cornea 2003; 22:332-7. [PMID:
12792476]
26. Sosne G, Albeiruti AR, Hollis B, Siddiqi A, Ellenberg D,
Kurpakus-Wheater M. Thymosin beta4 inhibits
benzalkonium chloride-mediated apoptosis in corneal and
conjunctival epithelial cells in vitro. Exp Eye Res 2006;
83:502-7. [PMID: 16630613]
27. Guenoun JM, Baudouin C, Rat P, Pauly A, Warnet JM,
Brignole-Baudouin F. In vitro study of inflammatory
potential and toxicity profile of latanoprost, travoprost, and
bimatoprost in conjunctiva-derived epithelial cells. Invest
Ophthalmol Vis Sci 2005; 46:2444-50. [PMID: 15980234]
28. Pauly A, Brignole-Baudouin F, Guenoun JM, Riancho L, Rat
P, Warnet JM, Baudouin C. Comparative study of topical anti-
allergic eye drops on human conjunctiva-derived cells:
responses to histamine and IFNgamma and toxicological
profiles. Graefes Arch Clin Exp Ophthalmol 2007;
245:534-46. [PMID: 16900358]
29. De Saint Jean M, Brignole F, Feldmann G, Goguel A, Baudouin
C. Interferon-gamma induces apoptosis and expression of
inflammation-related proteins in Chang conjunctival cells.
Invest Ophthalmol Vis Sci 1999; 40:2199-212. [PMID:
10476784]
30. De Saint Jean M, Debbasch C, Rahmani M, Brignole F,
Feldmann G, Warnet JM, Baudouin C. Fas- and interferon
gamma-induced apoptosis in Chang conjunctival cells:
further investigations. Invest Ophthalmol Vis Sci 2000;
41:2531-43. [PMID: 10937564]
31. Zhan H, Towler HM, Calder VL. The immunomodulatory role
of human conjunctival epithelial cells. Invest Ophthalmol Vis
Sci 2003; 44:3906-10. [PMID: 12939308]
32. Lavappa KS, Macy ML, Shannon JE. Examination of ATCC
stocks for HeLa marker chromosomes in human cell lines.
Nature 1976; 259:211-3. [PMID: 1250349]
33. Buron N, Micheau O, Cathelin S, Lafontaine PO, Creuzot-
Garcher C, Solary E. Differential mechanisms of conjunctival
cell death induction by ultraviolet irradiation and
benzalkonium chloride. Invest Ophthalmol Vis Sci 2006;
47:4221-30. [PMID: 17003409]
34. Calonge M, De Salamanca AE, Siemasko KF, Diebold Y, Gao
J, Juarez-Campo M, Stern ME. Variation in the expression of
inflammatory markers and neuroreceptors in human
conjunctival epithelial cells. Ocul Surf 2005; 3:S145-8.
[PMID: 17216105]
35. Diebold Y, Jarrin M, Saez V, Carvalho EL, Orea M, Calonge
M, Seijo B, Alonso MJ. Ocular drug delivery by liposome-
chitosan nanoparticle complexes (LCS-NP). Biomaterials
2007; 28:1553-64. [PMID: 17169422]
36. Enriquez de Salamanca A, Siemasko KF, Diebold Y, Calonge
M, Gao J, Juarez-Campo M, Stern ME. Expression of
muscarinic and adrenergic receptors in normal human
conjunctival epithelium. Invest Ophthalmol Vis Sci 2005;
46:504-13. [PMID: 15671275]
37. Huhtala A, Pohjonen T, Salminen L, Salminen A, Kaarniranta
K, Uusitalo H. In vitro biocompatibility of degradable
biopolymers in cell line cultures from various ocular tissues:
Direct contact studies. J Biomed Mater Res A 2007;
83:407-13. [PMID: 17450585]
38. Liu S, Li J, Tan DT, Beuerman RW. Expression and function
of muscarinic receptor subtypes on human cornea and
conjunctiva. Invest Ophthalmol Vis Sci 2007; 48:2987-96.
[PMID: 17591863]
39. Baudouin C, Riancho L, Warnet JM, Brignole F. In vitro studies
of antiglaucomatous prostaglandin analogues: travoprost with
and without benzalkonium chloride and preserved
latanoprost. Invest Ophthalmol Vis Sci 2007; 48:4123-8.
[PMID: 17724196]
40. Bruner LH, Carr GJ, Curren RD, Chamberlain M. Validation of
alternative methods for toxicity testing. Environ Health
Perspect 1998; 106:477-84. [PMID: 9599695]
41. Draize JH, Woodward G, Calvery HO. Methods for the study
of irritation and toxicity of substances applied topically to the
skin and mucous membranes. J Pharmacol Exp Ther 1944;
82:377-90.
42. Vinardell MP, Mitjans M. Alternative methods for eye and skin
irritation tests: An overview. J Pharm Sci 2008; 97:46-59.
[PMID: 17701961]
Molecular Vision 2008; 14:394-402 <http://www.molvis.org/molvis/v14/a48> © 2008 Molecular Vision
The print version of this article was created on 4 March 2008. This reflects all typographical corrections and errata to the article
through that date. Details of any changes may be found in the online version of the article.
402